BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10699024)

  • 1. Comparison of two commercial methods for measurement of cytomegalovirus load in blood samples after renal transplantation.
    Tong CY; Cuevas LE; Williams H; Bakran A
    J Clin Microbiol; 2000 Mar; 38(3):1209-13. PubMed ID: 10699024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma.
    Caliendo AM; Schuurman R; Yen-Lieberman B; Spector SA; Andersen J; Manjiry R; Crumpacker C; Lurain NS; Erice A;
    J Clin Microbiol; 2001 Apr; 39(4):1334-8. PubMed ID: 11283052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients.
    Piiparinen H; Höckerstedt K; Grönhagen-Riska C; Lautenschlager I
    J Clin Virol; 2004 Jul; 30(3):258-66. PubMed ID: 15135746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
    Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S
    J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the AMPLICOR cytomegalovirus test with specimens from human immunodeficiency virus-infected subjects.
    Boivin G; Handfield J; Toma E; Murray G; Lalonde R; Tevere VJ; Sun R; Bergeron MG
    J Clin Microbiol; 1998 Sep; 36(9):2509-13. PubMed ID: 9705384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CMV antigenemia and quantitative viral load assessments in hematopoietic stem cell transplant recipients.
    Cardeñoso L; Pinsky BA; Lautenschlager I; Aslam S; Cobb B; Vilchez RA; Hirsch HH
    J Clin Virol; 2013 Feb; 56(2):108-12. PubMed ID: 23146665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between the quantitative antigenemia assay and the cobas amplicor monitor quantitative PCR assay for detecting CMV viraemia in bone marrow and solid organ transplant patients.
    Flexman J; Kay I; Fonte R; Herrmann R; Gabbay E; Palladino S
    J Med Virol; 2001 Jul; 64(3):275-82. PubMed ID: 11424115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients.
    Rollag H; Sagedal S; Kristiansen KI; Kvale D; Holter E; Degré M; Nordal KP
    Clin Microbiol Infect; 2002 Jul; 8(7):431-4. PubMed ID: 12199854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of molecular techniques in prediction and diagnosis of cytomegalovirus disease in immunocompromised patients.
    Szczepura A; Westmoreland D; Vinogradova Y; Fox J; Clark M
    Health Technol Assess; 2006 Apr; 10(10):1-176. PubMed ID: 16595079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction and diagnosis of cytomegalovirus disease in renal transplant recipients using qualitative and quantitative polymerase chain reaction.
    Tong CY; Cuevas LE; Williams H; Bakran A
    Transplantation; 2000 Mar; 69(5):985-91. PubMed ID: 10755562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation.
    Gentile G; Picardi A; Capobianchi A; Spagnoli A; Cudillo L; Dentamaro T; Tendas A; Cupelli L; Ciotti M; Volpi A; Amadori S; Martino P; de Fabritiis P
    BMC Infect Dis; 2006 Nov; 6():167. PubMed ID: 17118205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: comparison with end-point PCR and pp65 antigen test.
    Allice T; Enrietto M; Pittaluga F; Varetto S; Franchello A; Marchiaro G; Ghisetti V
    J Med Virol; 2006 Jul; 78(7):915-22. PubMed ID: 16721848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCMV DNA detection and quantitation in the plasma and PBL of lung transplant recipients: COBAS Amplicor HCMV monitor test versus in-house quantitative HCMV PCR.
    Michaelides A; Facey D; Spelman D; Wesselingh S; Kotsimbos T
    J Clin Virol; 2003 Oct; 28(2):111-20. PubMed ID: 12957181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative detection of CMV DNA by PCR and hybridizaton methods in renal transplant recipients.
    Siennicka J; Rechnio M; Durlik M; Litwińska B; Kańtoch M
    Acta Microbiol Pol; 2000; 49(3-4):261-4. PubMed ID: 11293659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants.
    Preiser W; Bräuninger S; Schwerdtfeger R; Ayliffe U; Garson JA; Brink NS; Franck S; Doerr HW; Rabenau HF
    J Clin Virol; 2001 Jan; 20(1-2):59-70. PubMed ID: 11163584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the COBAS AMPLICOR CMV MONITOR test for detection of viral DNA in specimens taken from patients after liver transplantation.
    Sia IG; Wilson JA; Espy MJ; Paya CV; Smith TF
    J Clin Microbiol; 2000 Feb; 38(2):600-6. PubMed ID: 10655353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of cytomegalovirus (CMV) viral load by the hybrid capture assay allows for early detection of CMV disease in lung transplant recipients.
    Bhorade SM; Sandesara C; Garrity ER; Vigneswaran WT; Norwick L; Alkan S; Husain AN; McCabe MA; Yeldandi V
    J Heart Lung Transplant; 2001 Sep; 20(9):928-34. PubMed ID: 11557186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Murex CMV DNA Hybrid Capture assay (version 2.0) for early diagnosis of cytomegalovirus infection in recipients of an allogeneic stem cell transplant.
    Hebart H; Wuchter P; Loeffler J; Gscheidle B; Hamprecht K; Sinzger C; Jahn G; Dietz K; Kanz L; Einsele H
    Bone Marrow Transplant; 2001 Jul; 28(2):213-8. PubMed ID: 11509941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of molecular assays in diagnosis and monitoring of cytomegalovirus disease following renal transplantation.
    Aitken C; Barrett-Muir W; Millar C; Templeton K; Thomas J; Sheridan F; Jeffries D; Yaqoob M; Breuer J
    J Clin Microbiol; 1999 Sep; 37(9):2804-7. PubMed ID: 10449456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Murex CMV DNA hybrid capture assay for detection and quantitation of cytomegalovirus infection in patients following allogeneic stem cell transplantation.
    Hebart H; Gamer D; Loeffler J; Mueller C; Sinzger C; Jahn G; Bader P; Klingebiel T; Kanz L; Einsele H
    J Clin Microbiol; 1998 May; 36(5):1333-7. PubMed ID: 9574700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.